Article: FORM 8-K: BIOCUREX ANNOUNCES APPOINTMENT OF CFO

WASHINGTON, Oct. 30 -- Biocurex, Inc., British Columbia, Canada, files Form 8-K (current report) with Securities and Exchange Commission on Oct. 30 to announce change in designation of Gladys Chan.

Exact name of registrant as specified in its charter is BIOCUREX, INC.

State of Incorporation: Texas

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(c) On Oct. 26 (the "Effective Date"), BioCurex, Inc. (OTCBB: BOCX) (the "Company") promoted Gladys Chan, its comptroller, to the position of Chief Financial Officer. As Chief Financial Officer, Ms. Chan will be serving at the pleasure of the Company's ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!